BSMA Posts
How Has the Evolution of Supply Chains Advanced Nations and Economies?
The Forrester Moment: How System Dynamics Created Modern Supply Chain Management
Five Transformative Innovations That Changed the Trajectory of Supply Chain Management
The Next Five Years: Artificial Intelligence and the Re-engineering of Supply Chains (2026–2031)
Supply Chains: The Operating System of Nations
Revitalizing the Life Sciences Supply Chain of USA and Europe After the Coronavirus Pandemic
The current economic devastation of USA and Europe caused by the Coronavirus pandemic has produced a vision of how the Life Sciences industry could be shaped for the synergistic benefit to the two economies in the world. In order to develop a future state, let us look...
TOP TEN TENETS For The EVOLUTION Of An“ANTIFRAGILE” SUPPLY CHAIN Of LIFE SCIENCES
History has taught us that it is in the DNA of America to emerge from a crisis better than before. This time of the Coronavirus pandemic, it is shaping up to be no different. Today the healthcare industry in America has been stressed, disrupted and devastated with...
Supply chain planning in the time of Coronavirus!
The recent outbreak of the COVID-19 (Coronavirus) and the related supply chain interruptions has highlighted the vulnerability of global supply chains. Initial concern related to shutdowns in China production but as this country worked through the issues and restarted...
Mitigating US Dependence On China For Biopharmaceutical APIs & Drugs
A widespread awakening from the current coronavirus epidemic is how vulnerable the bio-pharmaceutical supply chain of the US is on supply from China. As the spread of COVID-19 has witnessed shortages of PPE, masks and ventilators causing loss of human lives, the issue...
Molecular Diagnostics Supply Chain and Breakthrough Therapies In Development: An Update!
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While the majority of cases result in mild symptoms, some progress to pneumonia and multi-organ failure. As of March 28, 2020, the...
Are supply chains ready in the life sciences and pharmaceuticals for “Made in the USA” or “Made in Europe” and the Inherent Challenges to Making the Adjustment
In the wake of the Covid-19 pandemic, I and many others have witnessed our reliance on China and Asian countries for basic medical supplies (such as gowns, masks, gloves, and ventilators), leave aside many pharmaceuticals and active ingredients are made in China. This...